GUTS
Fractyl Health Inc.

1,790
Mkt Cap
$72.63M
Volume
2.07M
52W High
$3.03
52W Low
$0.3772
PE Ratio
-0.23
GUTS Fundamentals
Price
$0.4647
Prev Close
$0.4578
Open
$0.4676
50D MA
$0.6478
Beta
1.30
Avg. Volume
2.66M
EPS (Annual)
-$1.86
P/B
7.54
Rev/Employee
$0.00
$146.91
Loading...
Loading...
News
all
press releases
Fractyl Health (GUTS) Projected to Post Quarterly Earnings on Monday
Fractyl Health (NASDAQ:GUTS) will be releasing its Q4 2025 earnings on Monday, April 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-6-fractyl-health-inc-stock...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Scalable Biotech Manufacturing Unlocks a $14B Market
Scalable Biotech Manufacturing Unlocks a $14B Market Scalable Biotech Manufacturing Unlocks a $14B Market PR Newswire VANCOUVER, BC, March 27, 2026 Issued on behalf of Ava Bio, Inc.VANCOUVER, BC, March 27, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary The global cell therapy manufacturing...
PR Newswire·6d ago
News Placeholder
HC Wainwright Forecasts Fractyl Health Q1 Earnings
Fractyl Health, Inc. (NASDAQ:GUTS - Free Report) - Research analysts at HC Wainwright issued their Q1 2026 earnings estimates for shares of Fractyl Health in a research report issued on Wednesday...
MarketBeat·6d ago
News Placeholder
Fractyl Health, Inc. (NASDAQ:GUTS) Receives Average Recommendation of "Hold" from Analysts
Fractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) has received an average recommendation of "Hold" from the five brokerages that are covering the company, Marketbeat Ratings reports. One...
MarketBeat·6d ago
News Placeholder
Short Interest in Fractyl Health, Inc. (NASDAQ:GUTS) Decreases By 55.7%
Fractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) was the target of a significant decrease in short interest in March. As of March 13th, there was short interest totaling 5,831,445 shares, a...
MarketBeat·6d ago
News Placeholder
Fractyl Health (NASDAQ:GUTS) Earns Buy Rating from Canaccord Genuity Group
Canaccord Genuity Group restated a "buy" rating and issued a $8.00 price objective on shares of Fractyl Health in a report on Thursday...
MarketBeat·6d ago
News Placeholder
Fractyl Health FY2029 EPS Forecast Lifted by HC Wainwright
Fractyl Health, Inc. (NASDAQ:GUTS - Free Report) - Investment analysts at HC Wainwright upped their FY2029 earnings per share (EPS) estimates for shares of Fractyl Health in a report issued on Wednesday, March 25th. HC Wainwright analyst J. Pantginis now expects that the company will post earnings o...
MarketBeat·7d ago
News Placeholder
Fractyl Health (GUTS) Stock Jumps 21% After Hours: Here's What You Should Know
Fractyl Health's shares jumped 20.9% after hours following its Q4 2025 results and new weight-maintenance data from the REMAIN-1 Midpoint Cohort.read more...
Benzinga·8d ago
News Placeholder
Fractyl Health Q4 Earnings Call Highlights
Fractyl Health (NASDAQ:GUTS) used its fourth-quarter and full-year 2025 results call to sharpen its investment narrative around Revita, its endoscopic procedure aimed at helping patients maintain...
MarketBeat·8d ago
News Placeholder
Fractyl Health (NASDAQ:GUTS) Releases Earnings Results, Misses Expectations By $0.13 EPS
Fractyl Health (NASDAQ:GUTS - Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.32) earnings per share (EPS) for the quarter, missing the consensus estimate...
MarketBeat·8d ago
<
1
2
...
>

Latest GUTS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.